Canopy Growth Corp., (TSX: WEED), owner of Tweed, Bedrocan, and Mettrum, has announced the details of a “rigorous” pesticide testing program outlining procedures that include equipment, production rooms, and pre-release third party testing.
The company, which holds medical cannabis cultivation licenses in Canada, indicated they have shipped over “300,000 orders, representing 7 million grams” of cannabis that has never been subject to a product recall. Canopy operates five facilities covering 655,000 square feet in total.
“Tweed and its sister companies have always had the most rigorous quality assurance and testing procedures in place to protect our clients,” Chairman and CEO Bruce Linton said in a press release. “As part of our move to a single store for all clients, we are formalizing the program so customers can understand the processes we have in place for every product they buy.”
The program details indicate the company employs 38 staff “dedicated solely to quality assurance” and that nothing enters their production facilities without the sign-off of a quality control professional. In addition to pesticides, the company’s testing program – for which “typical” lot release reports can reach more than 100 pages – includes THC and CBD content, black mold-produced aflatoxins, heavy metals, and microbiological tests.
Get daily cannabis business news updates. Subscribe
End
